Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2012
09/27/2012US20120246757 Modulation of cellular protein function by artificial sumo ligases
09/27/2012US20120246755 Brassica plants comprising mutant fad3 alleles
09/27/2012US20120246754 Soybean cultivar by0912810
09/27/2012US20120246753 Soybean cultivar by0811023
09/27/2012US20120246752 Soybean cultivar by0811143
09/27/2012US20120246750 Soybean cultivar hi0912797
09/27/2012US20120246749 Cotton variety fm 9250gl
09/27/2012US20120246748 Isolated novel acid and protein molecules from soy and methods of using those molecules to generate transgene plants with enhanced agronomic traits
09/27/2012US20120246747 Rna-interference by single-stranded rna molecules
09/27/2012US20120246746 Method for Generating Immune-Compatible Cells and Tissues Using Nuclear Transfer Techniques
09/27/2012US20120245339 Novel glyphosate-n-acetyltransferase (gat) genes
09/27/2012US20120245338 Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
09/27/2012US20120245334 Methods of using fet labeled oligonucleotides that include a 3'-5' exonuclease resistant quencher domain and compositions for practicing the same
09/27/2012US20120245331 Modified biotin-binding protein
09/27/2012US20120245326 Spider mite silk proteins
09/27/2012US20120245221 Anti-apoptotic agents and uses thereof
09/27/2012US20120245220 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing
09/27/2012US20120245218 Surface modified nanoparticles, methods of their preparation, and uses thereof for gene and drug delivery
09/27/2012US20120245217 RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
09/27/2012US20120245100 Plasmid for expression of transgenes in plants
09/27/2012US20120245092 Polypeptides having modulatory effects on cells
09/27/2012US20120245091 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
09/27/2012US20120245046 Gene expression profiling from ffpe samples
09/27/2012US20120245040 Methods for synthesis of encoded libraries
09/27/2012US20120244622 Regulated gene expression systems and constructs thereof
09/27/2012US20120244621 Tumor-specific bacterial promoter elements
09/27/2012US20120244615 Isolated a-type fhf n-terminal domain peptides and methods of use
09/27/2012US20120244613 Human micrornas and methods for inhibiting same
09/27/2012US20120244601 Riboswitch based inducible gene expression platform
09/27/2012US20120244600 Swine influenza hemagglutinin variants
09/27/2012US20120244596 Anticalins
09/27/2012US20120244588 Method of producing 3-hydroxypropionic acid using malonic semialdehyde reducing pathway
09/27/2012US20120244586 3-hydroxypropionic acid and other organic compounds
09/27/2012US20120244584 Engineering microorganisms
09/27/2012US20120244578 Monomeric antibody fc
09/27/2012US20120244576 Compositions and methods for improved protein production
09/27/2012US20120244575 Cyclotide genes in the fabaceae plant family
09/27/2012US20120244569 Quantum dot carrier peptide conjugates suitable for imaging and delivery applications in plants
09/27/2012US20120244565 Mutant enzyme and application thereof
09/27/2012US20120244560 Monoclonal antibody against human hig-1 polypeptide
09/27/2012US20120244189 Treatment of infections
09/27/2012US20120244185 Immunization strategy to prevent h1n1 infection
09/27/2012US20120244184 Modified peptide vaccine derived from influenza m2
09/27/2012US20120244183 Influenza viruses and uses thereof
09/27/2012US20120244180 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
09/27/2012US20120244178 Plasmodium falciparum antigens
09/27/2012US20120244176 Protein having immunogenicity of cedar pollen, polynucleotide encoding the protein, and use thereof
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012US20120244174 Treatment of tauopathies
09/27/2012US20120244166 Neutralizing antibodies to hiv-1 and their use
09/27/2012US20120244164 Biological materials related to c-met
09/27/2012US20120244163 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
09/27/2012US20120244162 Cross-species-specific bispecific binders
09/27/2012US20120244154 Activatable Binding Polypeptides and Methods of Identification and Use Thereof
09/27/2012US20120244152 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
09/27/2012US20120244148 Anti-interferon-alpha antibodies
09/27/2012US20120244132 T-cell receptor
09/27/2012US20120244131 Method for modulating the efficiency of double-strand break-induced mutagenesis
09/27/2012US20120244127 AAV Vectors Expressing SEC10 for Treating Kidney Damage
09/27/2012US20120244113 Immunogenic composition and methods
09/27/2012US20120244112 Mutant interleukin-2 polypeptides
09/27/2012DE112010002842T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation
09/27/2012DE112010000887T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation
09/27/2012CA2836007A1 Mouse anti-aggrus monoclonal antibodies
09/27/2012CA2832703A1 Nitrogen fixation gene island suitable for expressing in prokaryotic and eukaryotic systems
09/27/2012CA2831144A1 Methods for producing a complex transgenic trait locus
09/27/2012CA2831130A1 Host cells and methods for production of isobutanol
09/27/2012CA2831125A1 Recombinant alsv for preventing pathogenic viral infection of plant
09/27/2012CA2831085A1 Transgenic plants expressing dispersinb
09/27/2012CA2831000A1 Method of recovering plant-derived proteins
09/27/2012CA2830901A1 Immunogenic compositions in particulate form and methods for producing the same
09/27/2012CA2830805A1 Constructs and method for regulating gene expression or for detecting and controlling a dna locus in eukaryotes
09/27/2012CA2830772A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
09/27/2012CA2830628A1 Composition for treatment and diagnosis of pancreatic cancer
09/27/2012CA2830600A1 Compositions and methods for enhancing the pluripotency of stem cells
09/27/2012CA2830531A1 Quantum dot carrier peptide conjugates suitable for imaging and delivery applications in plants
09/27/2012CA2830373A1 Method for producing polymer, method for producing organic acid, and organic acid-producing microorganism
09/27/2012CA2829941A1 In situ expression of lipase for enzymatic production of alcohol esters during fermentation
09/27/2012CA2828931A1 Regulatory regions preferentially expressing in non-pollen plant tissue
09/27/2012CA2828196A1 Promoters for regulating expression in plants
09/27/2012CA2820956A1 Methods and compositions comprising il-7 receptor ligands
09/26/2012EP2503001A1 Use of rice polypeptides/nucleic acids for plant improvement
09/26/2012EP2503000A1 Plants having enhanced yield-related traits and a method for making the same
09/26/2012EP2502999A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
09/26/2012EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile
09/26/2012EP2502997A1 MicroRNA inhibiting nucleic acid molecule
09/26/2012EP2502996A2 Anti-FGF23 antibody and pharmaceutical composition comprising the same
09/26/2012EP2502995A1 Pharmaceutical composition
09/26/2012EP2502994A1 Primer set for amplification of mthfr gene, mthfr gene amplification reagent comprising same, and use of same
09/26/2012EP2502993A1 Human artificial chromosome vector
09/26/2012EP2502992A1 Human artificial chromosome vector
09/26/2012EP2502991A1 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated
09/26/2012EP2502939A1 Nonnatural collagen-like protein and use thereof
09/26/2012EP2502938A2 Antibodies and immunoconjugates and uses therefor
09/26/2012EP2502937A2 Anti-CD 79b Antibodies And Immunoconjugates And Methods Of Use
09/26/2012EP2502936A1 Highly-functional mutant of humanized anti-egfr antibody variable region
09/26/2012EP2502935A2 Improved antibodies having altered effector function and methods for making the same
09/26/2012EP2502496A1 Flowering inducer
09/26/2012EP2502076A2 Methods for detecting a mycobacterium tuberculosis infection
09/26/2012EP2501828A2 Genetic markers for weight management and methods of use thereof
1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 4023